Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Mar-Apr;16(2):101086.
doi: 10.1016/j.jaim.2024.101086. Epub 2025 Mar 28.

Acute urinary retention following frequent administration of Guggulu Tiktakam Kwatha and its management - a case report

Affiliations
Case Reports

Acute urinary retention following frequent administration of Guggulu Tiktakam Kwatha and its management - a case report

Praveen Balakrishnan et al. J Ayurveda Integr Med. 2025 Mar-Apr.

Abstract

A 72-year-old male patient, a diagnosed case of infective spondylodiscitis, was admitted in our hospital for severe pain in the right hip and lower back (in the lumbo-sacral region) in a non-ambulatory mode. Considering the criticality, we administered Kwatha in a Muhurmuhu (frequent administration) schedule. The initial medicines reduced pain, but not the elevated C-reactive protein (CRP). To reduce this elevated CRP, we administered Amruthotharam Kwatha and Guggulu Tiktakam Kwatha (GTK) in the dosage of 30 ml every 2 h for eight times. CRP started reducing, but we encountered an acute urinary retention as an adverse drug reaction. Naranjo Adverse Drug Reaction Probability Scale recording gave a score of eight, which shows that the AE could be probably due to administration of Guggulu Tiktakam Kwatha (GTK) in Muhurmuhu schedule. When the patient did not void urine for more than 6 hours, we did Marma therapy on left Mootthira Kala Marma. The patient voided urine within half an hour of Marma therapy. Clinically, after the medications, pain reduced considerably, CRP came to normal, and the patient came to an ambulatory mode. This case report shows that medicines like GTK should cautiously be administered, as it may complicate. This case report also focusses light on the fact that Marma therapy could be a possible mode of tackling acute conditions.

Keywords: Adverse effect; Ayurveda; C-Reactive protein; Guggulu Tiktakam Kwatha; Intensive ayurveda care; Marma therapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Showing the left Moothira-kala Marma (in circle).
Fig. 2
Fig. 2
The probable mode of adverse event in administration of high dose of GTK.

References

    1. National Institute of Indian Medical Heritage Caraka Samhita E-Book Cent Counc Res Ayurvedic Sci (CCRAS) 2010;2010 http://niimh.nic.in/ebooks/ecaraka/ Available at:
    1. Institute of Ayurveda and Integrative Medicine (I-AIM) 2010. http://vedotpatti.in/samhita/Vag/ehrudayam/?mod=read (Astanga Hrudayam E-book. e-hrudayam - Inst Ayurveda Integr Med (I-AIM)). Available from.
    1. Mukhopadhyay S., Abraham S.E., Holla B., Ramakrishna K.K., Gopalakrishna K.L., Soman A., Chikkanna U.C., Bharath M.M.S., Bhargav H., Varambally S., Gangadhar B.N. Heavy metals in Indian traditional systems of medicine: a systematic scoping review and recommendations for integrative medicine practice. J Alternative Compl Med. 2021;27(11):915–929. doi: 10.1089/acm.2021.0083. PMID: 34142855. - DOI - PubMed
    1. Ajanal M., Nayak S., Prasad B.S., Kadam A. Adverse drug reaction and concepts of drug safety in Ayurveda: an overview. J Young Pharm. 2013;5(4):116–120. doi: 10.1016/j.jyp.2013.10.001. PMID: 24563588; PMCID: PMC3930110. - DOI - PMC - PubMed
    1. Paudyal B., Thapa A., Sigdel K.R., Adhikari S., Basnyat B. Adverse events with ayurvedic medicines- possible adulteration and some inherent toxicities. Welcome Open Res. 2019;4:23. doi: 10.12688/wellcomeopenres.15096.3. PMID: 31641694; PMCID: PMC6790910. - DOI - PMC - PubMed

Publication types